Press release
DSM Exhibits Pioneering Pharmaceutical Technologies and Solutions at CPHI 2022
18 Oct 2022
Our commitment to innovation is unparalleled. Partnering with DSM ensures access to a global network of application labs and expert knowledge, for all your new product development needs.
We have a strong track record of joint innovation and collaboration with key opinion leaders, providing crucial API support across specific applications. We can tailor our approach to match your requirements, developing high-quality, sustainable products that take you further in the pharmaceutical industry.
Contact us to explore how our unique technical capabilities can help you get to market faster.
Global regulatory bodies have introduced a legal obligation for drug manufacturers to implement mitigation strategies that aim to minimize the risk of nitrosamine formation in drug products. The addition of antioxidants to drug formulations is a safe and viable, FDA-recommended mitigation strategy for inhibition of nitrosamine formation in drug products. Prevention of formation of potentially carcinogenic impurities is possible with commonly used ascorbic acid and alpha-tocopherol.
18 Oct 2022
14 Jul 2022 | 4 min
25 May 2022 | 4 min
16 May 2022 | 6 min
21 Jan 2022 | 4 min
06 Dec 2021 | 4 min
03 Nov 2021 | 4 min
22 Jul 2021 | 3 min
26 May 2021 | 3 min
07 Apr 2021 | 4 min
17 Feb 2021 | 4 min
14 Dec 2020 | 4 min
29 Oct 2020 | 7 min
29 Sep 2020 | 7 min
02 Sep 2020 | 7 min
31 Jul 2020 | 8 min
18 Feb 2020 | 5 min
Request samples, place orders and view product documentation
Download the latest copy of our Solutions Catalogue
We’re more than a partner. We’re a competitive edge.
The latest in vitamin and lipid research and industry developments
Academic studies and the latest science in educational modules
Videos exploring the growing role of vitamin APIs and lipid API intermediates
